CR-CP Life Science Fund
News,Biotech / MedTech,Singapore,Investments
MiRXES secures $77M Series C funding to accelerate multi-cancer early detection pipeline
Led by CR-CP Life Science Fund, this new capital will support MiRXES’s growth as a global leader in cancer early detection tests and preventive healthcare.
July 8, 2021
Lendela appoints new Singapore Country Manager and Head of Marketing
December 24, 2025
Lendela appoints new Singapore Country Manager and Head of Marketing
December 24, 2025




